Label: VITAMIN D- ergocalciferol capsule
- NDC Code(s): 64380-737-06, 64380-737-25
- Packager: Strides Pharma Science Limited
- Category: HUMAN PRESCRIPTION DRUG LABEL
- DEA Schedule: None
- Marketing Status: Abbreviated New Drug Application
Drug Label Information
Updated March 10, 2025
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
-
DESCRIPTIONErgocalciferol Capsules, USP are a synthetic calcium regulator for oral administration. Ergocalciferol is a white, colorless crystal, insoluble in water, soluble in organic solvents, and slightly ...
-
CLINICAL PHARMACOLOGYThe in vivo synthesis of the major biologically active metabolites of vitamin D occurs in two steps. The first hydroxylation of ergocalciferol takes place in the liver (to 25-hydroxyvitamin D ...
-
INDICATIONS AND USAGEErgocalciferol Capsules, USP are indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin D resistant rickets, and familial hypophosphatemia.
-
CONTRAINDICATIONSErgocalciferol Capsules, USP are contraindicated in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin D, and hypervitaminosis D.
-
WARNINGSHypersensitivity to vitamin D may be one etiologic factor in infants with idiopathic hypercalcemia. In these cases vitamin D must be strictly restricted. Keep out of the reach of children.
-
PRECAUTIONSGeneral - Vitamin D administration from fortified foods, dietary supplements, self-administered and prescription drug sources should be evaluated. Therapeutic dosage should be readjusted as soon ...
-
ADVERSE REACTIONSHypervitaminosis D is characterized by effects on the following organ system: Renal: Impairment of renal function with polyuria, nocturia, polydipsia, hypercalciuria, reversible azotemia ...
-
OVERDOSAGEThe effects of administered vitamin D can persist for two or more months after cessation of treatment. Hypervitaminosis D is characterized by: Hypercalcemia with anorexia, nausea, weakness ...
-
DOSAGE AND ADMINISTRATIONTHE RANGE BETWEEN THERAPEUTIC AND TOXIC DOSES IS NARROW. Vitamin D Resistant Rickets: 12,000 to 500,000 USP Units daily. Hypoparathyroidism: 50,000 to 200,000 USP Units daily concomitantly with ...
-
HOW SUPPLIEDEach capsule contains Vitamin D (Ergocalciferol) 1.25 mg equivalent to 50,000 USP Units. The green colored oval shaped transparent soft gelatin capsules are imprinted with '194' in white and ...
-
PACKAGE LABEL.PRINCIPAL DISPLAY PANELBottle of 100 capsules - Strides Pharma Inc - Rx only - NDC 64380-737-06 - Vitamin D - (Ergocalciferol Capsules, USP) 1.25 mg* (50,000 USP Units) WARNING: DO NOT EXCEED - RECOMMENDED ...
-
INGREDIENTS AND APPEARANCEProduct Information